two years. The results verified a difference in the platelet inhibitory effect of clopidogrel between patients with terapeut uppsala and without stent thrombosis but with a substantial overlap between cases and controls. Platelet function and genetic testing for identification of response to P2Y12 inhibition and the risk of stent thrombosis and myocardial infarction was investigated in a local case-control study (topas) of 169 patient recruited from the Swedish Coronary Angiograpy and Angioplasty Registry (scaar). Dr Asif Qasim is a consultant cardiologist (heart specialist) who offers private practice cardiology serivces in central and south London. Bupa Cromwell Hospital - please call to book. The results from this study will be presented in 2011. For doctors and health care professionals interested in cardiology and cardiovascular research please connect with t - the online professional network for discussion, education and training in cardiology.
National coordinator and member of the executive committee for the global RCT, tracer, comparing a thromin receptor inhibitor with placebo in ACS. The underlying mechanisms and the minimal importance of bradyarrhythmias and dyspnoea with ticagrelor have also been presented. Flather, London, and performed in UK, France, Poland, Spain and Italy, showed that a systematic improvement program can significantly improve the management of non-ST elevation acute coronary syndromes. Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the swedeheart register. The single center study, rebus, monitoring inflammatory and haemostasis parameters long-term (several borås restaurang lunch years) after AMI was started. Recently the phase III trial (appraise-2) comparing the best balance apixaban dose versus placebo was terminated by the safety committee after recrutiment of around 7000 patients because of a raised risk of severe bleeding not compensated by any reduction in ischemic events. In collaboration with SVA (professor Ulf Bondesson and Mikael Hedeland på SVA) we have studied PDE-5 inhibitors and the NO syntetase activity in pulmonary hypertension and have shown that PDE-5 inhibitors influence the NO-system and give acute hemodynamic effects. Evaluate new (and old) treatments, during the last years we have led three studies of adding oral anticoagulation to the current routine treatment with aspirin and clopdogrel as secondary prevention after acute coronary syndrome. Please feel free to contact Dr Qasim at if there are any sections of this website that you think can be improved. In a platelet substudy ticagrelor was verified to provide more pronounced and consistent inhibition than clopidogrel.